Literature DB >> 26361743

Luteolin as an anti-inflammatory and neuroprotective agent: A brief review.

Seyed Fazel Nabavi1, Nady Braidy2, Olga Gortzi3, Eduardo Sobarzo-Sanchez4, Maria Daglia5, Krystyna Skalicka-Woźniak6, Seyed Mohammad Nabavi7.   

Abstract

According to the World Health Organization, two billion people will be aged 60 years or older by 2050. Aging is a major risk factor for a number of neurodegenerative disorders. These age-related disorders currently represent one of the most important and challenging health problems worldwide. Therefore, much attention has been directed towards the design and development of neuroprotective agents derived from natural sources. These phytochemicals have demonstrated high efficacy and low adverse effects in multiple in vitro and in vivo studies. Among these phytochemicals, dietary flavonoids are an important and common chemical class of bioactive products, found in several fruits and vegetables. Luteolin is an important flavone, which is found in several plant products, including broccoli, pepper, thyme, and celery. Numerous studies have shown that luteolin possesses beneficial neuroprotective effects both in vitro and in vivo. Despite this, an overview of the neuroprotective effects of luteolin has not yet been accomplished. Therefore, the aim of this paper is to provide a review of the available literature regarding the neuroprotective effects of luteolin and its molecular mechanisms of action. Herein, we also review the available literature regarding the chemistry of luteolin, its herbal sources, and bioavailability as a pharmacological agent for the treatment and management of age-related neurodegenerative disorders.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer’s disease; Flavonoid; Luteolin; Neurotoxicity; Oxidative stress

Mesh:

Substances:

Year:  2015        PMID: 26361743     DOI: 10.1016/j.brainresbull.2015.09.002

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  76 in total

1.  Dietary Luteolin Reduces Proinflammatory Microglia in the Brain of Senescent Mice.

Authors:  Michael D Burton; Jennifer L Rytych; Ravi Amin; Rodney W Johnson
Journal:  Rejuvenation Res       Date:  2016-02-26       Impact factor: 4.663

Review 2.  Recent advances in our understanding of mast cell activation - or should it be mast cell mediator disorders?

Authors:  Theoharis C Theoharides; Irene Tsilioni; Huali Ren
Journal:  Expert Rev Clin Immunol       Date:  2019-04-22       Impact factor: 4.473

3.  Cell-Based Phenotypic Drug Screening Identifies Luteolin as Candidate Therapeutic for Nephropathic Cystinosis.

Authors:  Ester De Leo; Mohamed A Elmonem; Sante Princiero Berlingerio; Marine Berquez; Beatrice Paola Festa; Roberto Raso; Francesco Bellomo; Tobias Starborg; Manoe Jacoba Janssen; Zeinab Abbaszadeh; Sara Cairoli; Bianca Maria Goffredo; Rosalinde Masereeuw; Olivier Devuyst; Martin Lowe; Elena Levtchenko; Alessandro Luciani; Francesco Emma; Laura Rita Rega
Journal:  J Am Soc Nephrol       Date:  2020-06-05       Impact factor: 10.121

4.  Metabolomic Profiling and Neuroprotective Effects of Purslane Seeds Extract Against Acrylamide Toxicity in Rat's Brain.

Authors:  Ola M Farag; Reham M Abd-Elsalam; Hanan A Ogaly; Sara E Ali; Shymaa A El Badawy; Muhammed A Alsherbiny; Chun Guang Li; Kawkab A Ahmed
Journal:  Neurochem Res       Date:  2021-01-13       Impact factor: 3.996

5.  Protective effects of luteolin on the venous endothelium.

Authors:  Henrique Charlanti Reis Assunção; Yan Milen Coelho Cruz; Jéssica Silva Bertolino; Raphael Caio Tamborelli Garcia; Liliam Fernandes
Journal:  Mol Cell Biochem       Date:  2021-01-19       Impact factor: 3.396

Review 6.  Plant-Derived Natural Products in Cancer Research: Extraction, Mechanism of Action, and Drug Formulation.

Authors:  Wamidh H Talib; Izzeddin Alsalahat; Safa Daoud; Reem Fawaz Abutayeh; Asma Ismail Mahmod
Journal:  Molecules       Date:  2020-11-14       Impact factor: 4.411

7.  Luteolin prevents irinotecan-induced intestinal mucositis in mice through antioxidant and anti-inflammatory properties.

Authors:  Thaise Boeing; Priscila de Souza; Silvia Speca; Lincon Bordignon Somensi; Luisa Nathália Bolda Mariano; Benhur Judah Cury; Mariana Ferreira Dos Anjos; Nara Lins Meira Quintão; Laurent Dubuqoy; Pierre Desreumax; Luisa Mota da Silva; Sérgio Faloni de Andrade
Journal:  Br J Pharmacol       Date:  2020-02-15       Impact factor: 8.739

8.  Strategy for Tumor-Selective Disruption of Androgen Receptor Function in the Spectrum of Prostate Cancer.

Authors:  Rayna Rosati; Lisa Polin; Charles Ducker; Jing Li; Xun Bao; Dakshnamurthy Selvakumar; Seongho Kim; Besa Xhabija; Martha Larsen; Thomas McFall; Yanfang Huang; Benjamin L Kidder; Andrew Fribley; Janice Saxton; Hiroki Kakuta; Peter Shaw; Manohar Ratnam
Journal:  Clin Cancer Res       Date:  2018-09-05       Impact factor: 12.531

9.  Luteolin-induced vasorelaxation in uterine arteries from normal pregnant rats.

Authors:  Weiwei Yang; Qinghua Li; Jeremy W Duncan; Bhavisha A Bakrania; Jessica L Bradshaw; Joey P Granger; Sarosh Rana; Frank T Spradley
Journal:  Pregnancy Hypertens       Date:  2020-10-23       Impact factor: 2.899

10.  Luteolin alleviates cognitive impairment in Alzheimer's disease mouse model via inhibiting endoplasmic reticulum stress-dependent neuroinflammation.

Authors:  Jie-Jian Kou; Jun-Zhuo Shi; Yang-Yang He; Jiao-Jiao Hao; Hai-Yu Zhang; Dong-Mei Luo; Jun-Ke Song; Yi Yan; Xin-Mei Xie; Guan-Hua Du; Xiao-Bin Pang
Journal:  Acta Pharmacol Sin       Date:  2021-07-15       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.